Citigroup Has Lowered Expectations for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGLFree Report) had its price objective lowered by Citigroup from $2.50 to $1.75 in a research note published on Wednesday morning,Benzinga reports. Citigroup currently has a sell rating on the stock.

AGL has been the subject of several other reports. Stifel Nicolaus decreased their price objective on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research report on Tuesday. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Benchmark reissued a “buy” rating and set a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. TD Cowen lowered their price target on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price target on shares of agilon health in a research note on Wednesday, August 7th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $6.38.

Check Out Our Latest Stock Report on agilon health

agilon health Price Performance

Shares of NYSE AGL opened at $1.89 on Wednesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market cap of $776.66 million, a price-to-earnings ratio of -2.01 and a beta of 0.60. The stock’s 50-day moving average is $3.14 and its two-hundred day moving average is $4.90. agilon health has a 1-year low of $1.80 and a 1-year high of $13.76.

agilon health (NYSE:AGLGet Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the previous year, the company posted ($0.06) earnings per share. Analysts forecast that agilon health will post -0.35 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Steven Sell bought 20,000 shares of the stock in a transaction dated Thursday, September 12th. The shares were acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is owned by insiders.

Institutional Trading of agilon health

Institutional investors have recently modified their holdings of the business. J.Safra Asset Management Corp boosted its position in agilon health by 626.1% during the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after purchasing an additional 3,625 shares in the last quarter. City State Bank acquired a new stake in shares of agilon health during the third quarter worth $52,000. CWM LLC grew its holdings in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC acquired a new stake in shares of agilon health in the second quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC purchased a new stake in agilon health in the first quarter valued at approximately $65,000.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.